-+ 0.00%
-+ 0.00%
-+ 0.00%

Abpro and Celltrion Advance HER2×CD3 T-Cell Engager Toward Clinical Trials for HER2-Positive Cancers

Reuters·11/04/2025 12:04:43

Please log in to view news